{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T04:20:16Z","timestamp":1777868416993,"version":"3.51.4"},"reference-count":93,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30DK116074"],"award-info":[{"award-number":["P30DK116074"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01HL92473"],"award-info":[{"award-number":["1R01HL92473"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["I01BX001923"],"award-info":[{"award-number":["I01BX001923"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["I01BX000398"],"award-info":[{"award-number":["I01BX000398"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01BX001923"],"award-info":[{"award-number":["I01BX001923"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01BX000398"],"award-info":[{"award-number":["I01BX000398"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["IK6B004200"],"award-info":[{"award-number":["IK6B004200"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.mce.2019.110538","type":"journal-article","created":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T11:29:15Z","timestamp":1565609355000},"page":"110538","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Creosote bush-derived NDGA attenuates molecular and pathological changes in a novel mouse model of non-alcoholic steatohepatitis (NASH)"],"prefix":"10.1016","volume":"498","author":[{"given":"Lu","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie","family":"Bittner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dachuan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Cortez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hunter","family":"Dulay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Arshad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5150-1698","authenticated-orcid":false,"given":"Wen-Jun","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fredric B.","family":"Kraemer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salman","family":"Azhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mce.2019.110538_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.0959-9673.2006.00465.x","article-title":"Mouse models in non-alcoholic fatty liver disease and steatohepatitis research","volume":"87","author":"Anstee","year":"2006","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.mce.2019.110538_bib2","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mce.2019.110538_bib3","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jep.2005.02.002","article-title":"Larrea tridentata (Creosote bush), an abundant plant of Mexican and US-American deserts and its metabolite nordihydroguaiaretic acid","volume":"98","author":"Arteaga","year":"2005","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.mce.2019.110538_bib4","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1586\/erc.10.13","article-title":"Metabolic syndrome as a risk factor for diabetes","volume":"8","author":"Aschner","year":"2010","journal-title":"Expert Rev. Cardiovasc Ther."},{"key":"10.1016\/j.mce.2019.110538_bib5","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jhep.2016.05.005","article-title":"A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer","volume":"65","author":"Asgharpour","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mce.2019.110538_bib6","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1172\/JCI118177","article-title":"Alteration of the adrenal antioxidant defense system during aging in rats","volume":"96","author":"Azhar","year":"1995","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.mce.2019.110538_bib7","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.metabol.2016.04.004","article-title":"Pharmacological management of nonalcoholic fatty liver disease","volume":"65","author":"Barb","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.mce.2019.110538_bib8","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.mce.2019.110538_bib9","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1186\/1479-7364-4-6-411","article-title":"Evolutionary divergence and functions of the human acyl-CoA thioesterase gene ( ACOT ) family","volume":"4","author":"Brocker","year":"2010","journal-title":"Hum. Genom."},{"key":"10.1016\/j.mce.2019.110538_bib10","doi-asserted-by":"crossref","first-page":"15080","DOI":"10.1038\/nrdp.2015.80","article-title":"Nonalcoholic fatty liver disease","volume":"1","author":"Brunt","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.mce.2019.110538_bib11","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.mce.2019.110538_bib12","doi-asserted-by":"crossref","first-page":"20112","DOI":"10.3390\/ijms141020112","article-title":"Role of hepatic progenitor cells in nonalcoholic fatty liver disease development: cellular cross-talks and molecular networks","volume":"14","author":"Carpino","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mce.2019.110538_bib13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1124\/jpet.117.243733","article-title":"Nordihydroguaiaretic acid, a lignan from Larrea tridentate (Creosote Bush), protects against American Lifestyle-Induced Obesity Syndrome Diet-Induced Metabolic dysfunction in mice","volume":"365","author":"Chan","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.mce.2019.110538_bib14","doi-asserted-by":"crossref","first-page":"G483","DOI":"10.1152\/ajpgi.00079.2013","article-title":"Diet-induced mouse model of fatty liver disease and nonalcoholic steatohepatitis reflecting clinical disease progression and methods of assessment","volume":"305","author":"Clapper","year":"2013","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.mce.2019.110538_bib15","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2147\/DMSO.S13860","article-title":"Lifestyle modification in the management of the metabolic syndrome: achievements and challenges","volume":"3","author":"Dalle Grave","year":"2010","journal-title":"Diabetes Metabol. Syndr. Obes."},{"key":"10.1016\/j.mce.2019.110538_bib16","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/hep.510270601","article-title":"Hepatic steatosis: innocent bystander or guilty party?","volume":"27","author":"Day","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.mce.2019.110538_bib17","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","article-title":"Steatohepatitis: a tale of two \"hits\"?","volume":"114","author":"Day","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mce.2019.110538_bib18","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1194\/jlr.M700119-JLR200","article-title":"The acyl-CoA thioesterase I is regulated by PPARalpha and HNF4alpha via a distal response element in the promoter","volume":"48","author":"Dongol","year":"2007","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.mce.2019.110538_bib19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF00987601","article-title":"Phytotoxic properties of nordihydroguaiaretic acid, a lignan fromLarrea tridentata (Creosote bush)","volume":"11","author":"Elakovich","year":"1985","journal-title":"J. Chem. Ecol."},{"key":"10.1016\/j.mce.2019.110538_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116587","article-title":"Metabolic and tissue-specific regulation of acyl-CoA metabolism","volume":"10","author":"Ellis","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.mce.2019.110538_bib21","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1080\/10715760500419365","article-title":"Nordihydroguaiaretic acid is a potent in vitro scavenger of peroxynitrite, singlet oxygen, hydroxyl radical, superoxide anion and hypochlorous acid and prevents in vivo ozone-induced tyrosine nitration in lungs","volume":"40","author":"Floriano-Sanchez","year":"2006","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.mce.2019.110538_bib22","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.2337\/dc08-0423","article-title":"Metabolic syndrome and incident diabetes: current state of the evidence","volume":"31","author":"Ford","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.mce.2019.110538_bib23","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.2337\/db16-1519","article-title":"Acyl-CoA thioesterase 1 (ACOT1) regulates PPARalpha to couple fatty acid flux with oxidative capacity during fasting","volume":"66","author":"Franklin","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.mce.2019.110538_bib56","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jhep.2016.04.005","article-title":"Non-alcoholic fatty liver disease and cardiovascular risk: pathophysiological mechanisms and implications","volume":"65","author":"Francque","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mce.2019.110538_bib24","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00795-013-0016-1","article-title":"A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma","volume":"46","author":"Fujii","year":"2013","journal-title":"Med. Mol. Morphol."},{"key":"10.1016\/j.mce.2019.110538_bib25","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrd2005","article-title":"Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy","volume":"5","author":"Grundy","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.mce.2019.110538_bib26","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2217\/fca-2017-0019","article-title":"PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part II: PPAR-beta\/delta and PPAR-gamma","volume":"13","author":"Han","year":"2017","journal-title":"Future Cardiol."},{"key":"10.1016\/j.mce.2019.110538_bib27","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2217\/fca-2016-0059","article-title":"PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part I: PPAR-alpha","volume":"13","author":"Han","year":"2017","journal-title":"Future Cardiol."},{"key":"10.1016\/j.mce.2019.110538_bib28","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.drudis.2017.06.007","article-title":"Mouse models of nonalcoholic steatohepatitis in preclinical drug development","volume":"22","author":"Hansen","year":"2017","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.mce.2019.110538_bib29","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev-pathol-012615-044224","article-title":"Nonalcoholic fatty liver disease: pathogenesis and disease spectrum","volume":"11","author":"Hardy","year":"2016","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.mce.2019.110538_bib30","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/acel.12170","article-title":"Acarbose, 17-alpha-estradiol, and nordihydroguaiaretic acid extend mouse lifespan preferentially in males","volume":"13","author":"Harrison","year":"2014","journal-title":"Aging Cell"},{"key":"10.1016\/j.mce.2019.110538_bib31","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrgastro.2010.191","article-title":"Animal models of nonalcoholic fatty liver disease","volume":"8","author":"Hebbard","year":"2011","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mce.2019.110538_bib32","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","article-title":"Pathogenesis of liver fibrosis","volume":"6","author":"Hernandez-Gea","year":"2011","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.mce.2019.110538_bib33","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2174\/1573399054022820","article-title":"The metabolic syndrome and cardiovascular risk","volume":"1","author":"Hu","year":"2005","journal-title":"Curr. Diabetes Rev."},{"key":"10.1016\/j.mce.2019.110538_bib34","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1016\/j.ajpath.2015.06.004","article-title":"Hepatic progenitor cells in action: liver regeneration or fibrosis?","volume":"185","author":"Kaur","year":"2015","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.mce.2019.110538_bib35","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1210\/en.2003-1167","article-title":"High dietary fructose induces a hepatic stress response resulting in cholesterol and lipid dysregulation","volume":"145","author":"Kelley","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2019.110538_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1388-1981(00)00044-5","article-title":"Fatty acid import into mitochondria","volume":"1486","author":"Kerner","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mce.2019.110538_bib37","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.molmet.2014.02.002","article-title":"Integrated physiology and systems biology of PPARalpha","volume":"3","author":"Kersten","year":"2014","journal-title":"Mol. Metab."},{"key":"10.1016\/j.mce.2019.110538_bib38","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11894-008-0012-0","article-title":"Nonalcoholic fatty liver disease as a component of the metabolic syndrome","volume":"10","author":"Khashab","year":"2008","journal-title":"Curr. Gastroenterol. Rep."},{"key":"10.1016\/j.mce.2019.110538_bib39","doi-asserted-by":"crossref","first-page":"37246","DOI":"10.1074\/jbc.M604427200","article-title":"Overexpression of rat long chain acyl-coa synthetase 1 alters fatty acid metabolism in rat primary hepatocytes","volume":"281","author":"Li","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2019.110538_bib40","doi-asserted-by":"crossref","first-page":"27816","DOI":"10.1074\/jbc.M109.022467","article-title":"Liver-specific loss of long chain acyl-CoA synthetase-1 decreases triacylglycerol synthesis and beta-oxidation and alters phospholipid fatty acid composition","volume":"284","author":"Li","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2019.110538_bib41","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1111\/jgh.14046","article-title":"Hepatic peroxisome proliferator-activated receptor alpha mediates the major metabolic effects of Wy-14643","volume":"33","author":"Li","year":"2018","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mce.2019.110538_bib42","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s11154-014-9298-4","article-title":"Pharmacological treatment and therapeutic perspectives of metabolic syndrome","volume":"15","author":"Lim","year":"2014","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.mce.2019.110538_bib43","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/nrgastro.2013.171","article-title":"The global NAFLD epidemic","volume":"10","author":"Loomba","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mce.2019.110538_bib44","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jhep.2016.10.033","article-title":"The progenitor cell dilemma: cellular and functional heterogeneity in assistance or escalation of liver injury","volume":"66","author":"Lukacs-Kornek","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mce.2019.110538_bib45","article-title":"Mouse models of diet-induced nonalcoholic steatohepatitis reproduce the heterogeneity of the human disease","volume":"10","author":"Machado","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.mce.2019.110538_bib46","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-nutr-080508-141200","article-title":"Management of the metabolic syndrome and type 2 diabetes through lifestyle modification","volume":"29","author":"Magkos","year":"2009","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.mce.2019.110538_bib47","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2217\/17460875.2.4.465","article-title":"Long-chain acyl-CoA synthetases and fatty acid channeling","volume":"2","author":"Mashek","year":"2007","journal-title":"Future Lipidol."},{"key":"10.1016\/j.mce.2019.110538_bib48","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1586\/17446651.1.1.57","article-title":"Metabolic syndrome and risk for Type 2 diabetes","volume":"1","author":"Meigs","year":"2006","journal-title":"Expert Rev. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2019.110538_bib49","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrgastro.2013.183","article-title":"NAFLD, NASH and liver cancer","volume":"10","author":"Michelotti","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mce.2019.110538_bib50","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.jacc.2010.05.034","article-title":"The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis","volume":"56","author":"Mottillo","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.mce.2019.110538_bib51","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1006\/abio.1994.1357","article-title":"Measurement of plasma hydroperoxide concentrations by the ferrous oxidation-xylenol orange assay in conjunction with triphenylphosphine","volume":"220","author":"Nourooz-Zadeh","year":"1994","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.mce.2019.110538_bib93","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.mce.2019.110538_bib52","doi-asserted-by":"crossref","first-page":"858","DOI":"10.2174\/15701611113116660176","article-title":"Metabolic syndrome and cardiometabolic risk factors","volume":"11","author":"Papakonstantinou","year":"2013","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.mce.2019.110538_bib53","doi-asserted-by":"crossref","first-page":"E737","DOI":"10.1152\/ajpendo.00112.2006","article-title":"Overexpression of acyl-CoA synthetase-1 increases lipid deposition in hepatic (HepG2) cells and rodent liver in vivo","volume":"291","author":"Parkes","year":"2006","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2019.110538_bib54","doi-asserted-by":"crossref","first-page":"8591","DOI":"10.3390\/ijms15058591","article-title":"Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation","volume":"15","author":"Peverill","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mce.2019.110538_bib92","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3181\/00379727-202-43552","article-title":"Spectrophotometric measurement of plasma 2-thiobarbituric acid-reactive substances in the presence of hemoglobin and bilirubin interference","volume":"15","author":"Pyles","year":"1993","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.mce.2019.110538_bib55","doi-asserted-by":"crossref","DOI":"10.1621\/nrs.08002","article-title":"PPARalpha: energy combustion, hypolipidemia, inflammation and cancer","volume":"8","author":"Pyper","year":"2010","journal-title":"Nucl. Recept. Signal."},{"key":"10.1016\/j.mce.2019.110538_bib57","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0076-6879(94)33041-7","article-title":"Oxidative damage to proteins: spectrophotometric method for carbonyl assay","volume":"233","author":"Reznick","year":"1994","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.mce.2019.110538_bib58","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jhep.2017.05.016","article-title":"Treatment of NAFLD with diet, physical activity and exercise","volume":"67","author":"Romero-Gomez","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mce.2019.110538_bib59","doi-asserted-by":"crossref","first-page":"12466","DOI":"10.1038\/srep12466","article-title":"Characterization of hepatic lipid profiles in a mouse model with nonalcoholic steatohepatitis and subsequent fibrosis","volume":"5","author":"Saito","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mce.2019.110538_bib60","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jhep.2017.10.031","article-title":"Preclinical models of non-alcoholic fatty liver disease","volume":"68","author":"Santhekadur","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mce.2019.110538_bib61","doi-asserted-by":"crossref","first-page":"19269","DOI":"10.1074\/jbc.270.33.19269","article-title":"Induction of the acyl-coenzyme A synthetase gene by fibrates and fatty acids is mediated by a peroxisome proliferator response element in the C promoter","volume":"270","author":"Schoonjans","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2019.110538_bib62","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1172\/JCI66028","article-title":"Evolving therapies for liver fibrosis","volume":"123","author":"Schuppan","year":"2013","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.mce.2019.110538_bib63","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/bph.14528","article-title":"Anti-hyperlipidaemic effects of synthetic analogues of nordihydroguaiaretic acid in dyslipidaemic rats","volume":"176","author":"Singh","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.mce.2019.110538_bib64","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/nrendo.2011.72","article-title":"Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment","volume":"7","author":"Smith","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.mce.2019.110538_bib65","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1093\/gerona\/glu190","article-title":"Nordihydroguaiaretic acid extends the lifespan of Drosophila and mice, increases mortality-related tumors and hemorrhagic diathesis, and alters energy homeostasis in mice","volume":"70","author":"Spindler","year":"2015","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.mce.2019.110538_bib66","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/acel.12496","article-title":"Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an alpha-glucosidase inhibitor or a Nrf2-inducer","volume":"15","author":"Strong","year":"2016","journal-title":"Aging Cell"},{"key":"10.1016\/j.mce.2019.110538_bib67","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3168\/jds.S0022-0302(48)92228-0","article-title":"A study of the use of the antioxidant nordihydroguaiaretic acid in dairy products. I. Its antioxygenic properties in milk","volume":"31","author":"Stull","year":"1948","journal-title":"J. Dairy Sci."},{"key":"10.1016\/j.mce.2019.110538_bib68","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.3168\/jds.S0022-0302(48)92292-9","article-title":"A study of the use of the antioxidant nordihydroguaiaretic acid in dairy products. II. Its antioxygenic properties in unsweetened frozen cream","volume":"31","author":"Stull","year":"1948","journal-title":"J. Dairy Sci."},{"key":"10.1016\/j.mce.2019.110538_bib69","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.3748\/wjg.v18.i19.2300","article-title":"Animal models of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"18","author":"Takahashi","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.mce.2019.110538_bib70","doi-asserted-by":"crossref","first-page":"20704","DOI":"10.3390\/ijms141020704","article-title":"Multiple hits, including oxidative stress, as pathogenesis and treatment target in non-alcoholic steatohepatitis (NASH)","volume":"14","author":"Takaki","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mce.2019.110538_bib71","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.3748\/wjg.v19.i22.3375","article-title":"What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome?","volume":"19","author":"Tarantino","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.mce.2019.110538_bib72","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1210\/jc.2012-3093","article-title":"Clinical Review: nonalcoholic fatty liver disease: a novel cardiometabolic risk factor for type 2 diabetes and its complications","volume":"98","author":"Targher","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2019.110538_bib73","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMra0912063","article-title":"Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease","volume":"363","author":"Targher","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mce.2019.110538_bib74","doi-asserted-by":"crossref","first-page":"G987","DOI":"10.1152\/ajpgi.90272.2008","article-title":"Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent","volume":"295","author":"Tetri","year":"2008","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.mce.2019.110538_bib75","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.mce.2019.110538_bib76","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev-pathol-121808-102132","article-title":"Nonalcoholic fatty liver disease: pathology and pathogenesis","volume":"5","author":"Tiniakos","year":"2010","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.mce.2019.110538_bib77","doi-asserted-by":"crossref","first-page":"G762","DOI":"10.1152\/ajpgi.00476.2011","article-title":"Glucagon-like peptide-1 receptor agonism improves metabolic, biochemical, and histopathological indices of nonalcoholic steatohepatitis in mice","volume":"302","author":"Trevaskis","year":"2012","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.mce.2019.110538_bib78","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jhep.2018.03.011","article-title":"A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer","volume":"69","author":"Tsuchida","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mce.2019.110538_bib79","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/labinvest.2010.46","article-title":"Reversal of mouse Acyl-CoA oxidase 1 (ACOX1) null phenotype by human ACOX1b isoform [corrected]","volume":"90","author":"Vluggens","year":"2010","journal-title":"Lab. Investig."},{"key":"10.1016\/j.mce.2019.110538_bib80","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3390\/ijms17030367","article-title":"Bidirectional relationships and disconnects between NAFLD and features of the metabolic syndrome","volume":"17","author":"Wainwright","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mce.2019.110538_bib81","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/jps.3030340305","article-title":"A phytochemical investigation of Larrea divaricata Cav","volume":"34","author":"Waller","year":"1945","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.mce.2019.110538_bib82","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1146\/annurev-pharmtox-010617-052545","article-title":"Nonalcoholic steatohepatitis (NASH) and hepatic fibrosis: emerging therapies","volume":"58","author":"Wattacheril","year":"2018","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.mce.2019.110538_bib83","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1002\/hep.26986","article-title":"Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S","volume":"59","author":"Wong","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.mce.2019.110538_bib84","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrgastro.2013.149","article-title":"From NAFLD to NASH to cirrhosis-new insights into disease mechanisms","volume":"10","author":"Wree","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mce.2019.110538_bib85","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S2213-8587(14)70032-4","article-title":"Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome","volume":"2","author":"Yki-Jarvinen","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.mce.2019.110538_bib86","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mce.2019.110538_bib87","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/hep.29724","article-title":"Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"68","author":"Younossi","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.mce.2019.110538_bib88","doi-asserted-by":"crossref","first-page":"G72","DOI":"10.1152\/ajpgi.00328.2012","article-title":"Nordihydroguaiaretic acid improves metabolic dysregulation and aberrant hepatic lipid metabolism in mice by both PPARalpha-dependent and -independent pathways","volume":"304","author":"Zhang","year":"2013","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.mce.2019.110538_bib89","article-title":"Effect of Creosote bush-derived NDGA on expression of genes involved in lipid metabolism in liver of high-fructose fed rats: relevance to NDGA amelioration of hypertriglyceridemia and hepatic steatosis","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.mce.2019.110538_bib90","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12986-016-0121-y","article-title":"Microarray analysis of gene expression in liver, adipose tissue and skeletal muscle in response to chronic dietary administration of NDGA to high-fructose fed dyslipidemic rats","volume":"13","author":"Zhang","year":"2016","journal-title":"Nutr. Metab."},{"key":"10.1016\/j.mce.2019.110538_bib91","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.metabol.2016.01.010","article-title":"Nonalcoholic fatty liver disease and hepatocellular carcinoma","volume":"65","author":"Zoller","year":"2016","journal-title":"Metabolism"}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720719302400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720719302400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T11:54:38Z","timestamp":1777550078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720719302400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":93,"alternative-id":["S0303720719302400"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2019.110538","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Creosote bush-derived NDGA attenuates molecular and pathological changes in a novel mouse model of non-alcoholic steatohepatitis (NASH)","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mce.2019.110538","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110538"}}